Salary
Location
Germany
Department
Clinical Monitoring
Location
Germany
Remote Working
Remote
Job Categories
Clinical Monitoring
Job Type
Permanent
Description
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us
Reference
2025-119613
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Germany
Department
Clinical Trial Management
Location
Germany
Remote Working
Remote
Job Categories
Clinical Trial Management
Job Type
Permanent
Description
As a Manager, Site Engagement Liaison, you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence. The Site Engagement Liaison Mana
Reference
2025-119528
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Switzerland
Department
Clinical Monitoring
Location
Switzerland
Remote Working
Remote
Job Categories
Clinical Monitoring
Job Type
Permanent
Description
As a CRA II in Switzerland you will be joining the world's largest & most comprehensive clinical research organisation, powered by healthcare intelligence.You will be partnering with a pharmaceutical
Reference
2025-119372
Expiry date
01/01/0001
Read more
Shortlist Save this role
.png)
Teaser label
IndustryContent type
BlogsPublish date
05/29/2025
Summary
Blood Cancer Day Blood Cancer Day is a powerful reminder of the millions of individuals and families whose lives are affected by hematological malignancies every year. These diseases are complex,
.png)
Teaser label
IndustryContent type
BlogsPublish date
05/22/2025
Summary
World Schizophrenia Awareness Day 2025 Every year on 24 May, World Schizophrenia Awareness Day offers a vital opportunity to raise awareness, dismantle stigma, and celebrate the strength of individ
.png)
Teaser label
Inside ICONContent type
BlogsPublish date
05/08/2025
Summary
Standing Strong on Ovarian Cancer Day: ICON's Commitment to Advancing Care Ovarian cancer remains one of the most challenging gynaecologic malignancies, both in terms of detection and treatmen